190 likes | 327 Views
Hypophosphatemia Masquerading as Meningitis. L Wesley Aldred , MD; Melanie Mccauley , MD; Jason Pickett; Connell Knight; Mohammad Ullah , MD University of Mississippi Medical Center. Objectives. Review the causes of altered mental status
E N D
Hypophosphatemia Masquerading as Meningitis L Wesley Aldred, MD; Melanie Mccauley, MD; Jason Pickett; Connell Knight; Mohammad Ullah, MD University of Mississippi Medical Center
Objectives Review the causes of altered mental status Illustrate the importance of revisiting your differential diagnosis in the face of treatment failure Discuss how bisphosphonates contributed to this case Examine the signs and symptoms of hypophosphatemia
History 68 yo WF with RA and osteoporosis found unresponsive Found with fentanyl patch in place Some response to naloxone Complained of HA and stated that “pirates attacked [her] ship” Home medicines: fentanyl patch, alprazolam, butalbital-ASA-caffeine-codeine
Physical Exam VS: T 99.6, RR 22, BP 140/90, HR 105 C-collar in place Photophobia
Initial Differential Diagnosis Meningitis Drug overdose Intracranial lesion Electrolyte abnormalities
Investigations WBC 21.4 UDS: +benzodiazepines, +opiates, +barbiturates Acetaminophen <15 mcg/mL, salicylate <1 mg/dL, alcohol <10 mg/dL Na+ 130, K+ 2.9, Ca++ 9.3 Urinalysis negative for UTI
Investigations Lumbar puncture attempted by two physicians but unsuccessful
Initial Differential Diagnosis • Meningitis • SIRS+, CXR negative, UA normal • Drug overdose • Acute drug overdose vs chronic polypharmacy • Intracranial lesion • No large masses, no acute hemorrhage • No focal deficits to suggest ischemic event • Electrolyte abnormalities • Mild hyponatremia, hypokalemia • Take note, no Mg or Ph at admission
Hospital Course Admitted for sepsis secondary to meningitis Started on ceftriaxone, vancomycin, and ampicillin Hospital day 2: witnessed seizure activity, resolved with lorazepam Hospital day 3: developed vertical nystagmus and remained confused
Hospital Course Full electrolyte panel ordered given new nystagmus K+ 2.5 mmol/L, Ca++ 7.7 mg/dL, Mg 1.6 mg/dL, Ph 0.6 mg/dL Follow-up PTH found to be 278.3 pg/mL Replaced electrolytes hospital day 4: nystagmus and confusion resolved
Hospital Course Blood cultures negative Patient afebrile WBC trending down Hospital day 4: d/c antibiotics with continued improvement
Chart Review IV infusion of zoledronic acid 3 days prior to admission
Discussion • Causes of altered mental status • Meningitis • SIRS+, photophobia, CSF unable to be obtained • Drug overdose • Fentanyl patch, benzodiazepines, barbiturates • Responded to naloxone • CNS lesion • s/p fall; CT head negative for bleed • No focal deficits to suggest ischemic event • Electrolyte abnormalities • Not investigated thoroughly enough at admission
Discussion • Pathogenesis of hypophosphatemia after zoledronic acid infusion • Zoledronic acid decCa++ 2° hyperPTH decreabsorption of PO4 in proximal tubule • Decreased osteoclastic activity leads to decreased release of PO4 from bone compartment into serum
Discussion • SIRS and hypophosphatemia • Hypophosphatemia associated with cardiac arrhythmias • Hypophosphatemia shown to decrease diaphragmatic strength • Hypophosphatemia associated with leukocyte abnormalities
Discussion • Neurologic manifestations of hypophosphatemia • Metabolic encephalopathy resulting from ATP depletion • Mild irritability • Paresthesia • Generalized seizures • Coma
When All Else Fails… Blame the bisphosphonate
References Maalouf NM, Heller HJ, Odvina CV, Kim PJ, Sakhaee K. Bisphosphonate-induced hypocalcemia: report of 3 cases and review of literature. EndocrPract. 2006; 12 (1): 48-53. Rosen CJ, Brown S. Severe hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiency. N Engl J Med. 2003; 348 (15): 1503-4. Silvis SE, DiBartolomeo AG, Aaker HM. Hypophophatemia and neurological changes secondary to oral caloric intake: a variant of hyperalimentation syndrome. AM J Gastroenterol. 1980; 73 (3): 215-22. Subramanian R, Khardori R. Severe hypophosphatemia. Pathophysiologic implications, clinical presentations, and treatment. Medicine (Baltimore). 2000; 79 (1): 1-8. Kennel K, Drake M. Adverse effects of bisphosphonates: implications for osteoporosis management. Mayo Clinic Proc. Jul 2009; 85 (7): 632-638. Liamis G, Milionis HJ, Elisaf M. Medication-induced hypophosphatemia: a review. QJM. 2010; 103 (7): 449-59